Tirofiban on Fully Recanalized Stroke with Thrombectomy: A Propensity Score Matching Analysis

Table 2

Outcomes of patients after PSM.

Outcomes	Nontirofiban	Tirofiban	RR (95% CI)	value
3-month mRS 0∼2	36 (42.4%)	49 (57.6%)	1.361 (1.001–1.852)	0.046
Reocclusion	5 (5.9%)	3 (3.5%)	0.976 (0.912–1.043)	0.469
Any ICH	39 (45.9%)	29 (34.1%)	0.821 (0.641–1.053)	0.117
sICH	11 (12.9%)	8 (9.4%)	0.961 (0.864–1.069)	0.465
In-hospital mortality	7 (8.2%)	6 (7.1%)	0.987 (0.905–1.077)	0.773
3-month mortality	15 (17.6%)	9 (10.6%)	0.921 (0.815–1.041)	0.186

ICH, intracranial hemorrhage; sICH, systematic ICH; mRS, modified Rankin scale. The bold values mean P < 0.05.